SCHEMBL6840136

SCHEMBL6840136

Fc1ccc2c(c1)nc(C(F)(F)F)c1nc(-c3ccco3)n(CCC3CCNCC3)c12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR3 P51677 1/20 0.33
HRH1 P35367 1/20 0.32
KCNH2 Q12809 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
HSD17B10 Q99714 2/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
NPY1R P25929 1/20 0.30
P2RY6 Q15077 1/20 0.30
CASR P41180 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GLA P06280 1/20 0.30
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30
ALOX15 P16050 1/20 0.30
CASP1 P29466 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838074 0.92 ALDH1A1 (0.33) HRH1KCNH2HRH4HRH3HSD17B10
SCHEMBL6837741 0.91 NPY1R (0.37) HRH1KCNH2HRH4HRH3MAPT
SCHEMBL6838677 0.90 CASR (0.40) HSD17B10TSHRNPY1RCASRKDM4E
SCHEMBL6838564 0.87 KCNH2 (0.37) HRH1KCNH2HRH4HRH3HSD17B10
SCHEMBL6838620 0.87 SLC6A2 (0.38) HRH1KCNH2HSD17B10KDM4EMEN1
SCHEMBL6833986 0.86 AVPR2 (0.35) CCR3NPY1R
SCHEMBL6838596 0.84 CCR3 (0.34) CCR3NPY1R
SCHEMBL6838733 0.83 CCR3 (0.33) CCR3HSD17B10MAPTTSHRNPY1R
SCHEMBL6838630 0.83 NPY1R (0.35) HSD17B10TSHRNPY1RCASRKDM4E
SCHEMBL6838709 0.81 CCR3 (0.33) CCR3NPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 CCR3 66/4885HRH1 667/4885KCNH2 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.